ABSTRACT
OBJECTIVE: To observe the contribution of Borneolum syntheticum to the intervention effect of Liuwei Dihuang Pill (, LDP) on experimental retinal degeneration, and initially investigate the mechanism of Borneolum syntheticum as meridian-lead-in drug. METHODS: A total of 180 sodium iodateinduced retinital degeneration rats were randomly divided into three groups, including distilled water group, LDP group, and LDP+Borneolum syntheticum (LDP+BS) group. Twenty normal rats were fed regularly without any treatment as normal control. On day 7 and 14 after treatment, histopathological study and transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) test were performed to evaluate the retinopathy. Claudin-5 expression at blood-retina barrier (BRB) was detected by Western blot at different time points from 0.5 to 8 h after gavage. RESULTS: On day 7 and 14 after treatment, the retinal lesion grades were significantly different among the three groups (P<0.05). The grade in the LDP+BS group was significantly less than the LDP and distilled water groups (both P<0.05), no significant difference was observed between the LDP and distilled water groups (P>0.05). The apoptosis rates in the LDP+BS group was significantly less than the distilled water and LDP groups (both P<0.05), while there was no significant difference between LDP and distilled water groups (P>0.05). Expression of claudin-5 in LDP+BS group was significantly less than the other two groups at 0.5, 1 and 2 h after gavage (P<0.05). There was no apparent difference among the three groups at 4 and 8 h after gavage (P>0.05). CONCLUSION: Borneolum syntheticum could strengthen the effect of LDP on experimental retinal degeneration, indicated that Borneolum syntheticum might play the role of meridian-lead-in drug in the formula. The mechanism may be due to Borneolum syntheticum could promote the physiologically openness of bloodretina barrier through transiently affecting the expression of claudin-5.
Subject(s)
Drugs, Chinese Herbal/therapeutic use , Retinal Degeneration/chemically induced , Retinal Degeneration/drug therapy , Animals , Apoptosis/drug effects , Claudin-5/metabolism , Disease Models, Animal , Drugs, Chinese Herbal/pharmacology , Rats, Sprague-Dawley , Retinal Degeneration/pathology , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/pathology , Time FactorsABSTRACT
The Ag2MoO4-AgBr composite was prepared by a facile in-situ anion-exchange method, then the Ag nanoparticles were coated on this composite through photodeposition route to form a novel Ag@Ag2MoO4-AgBr composite. The in-situ Br(-) replacement in a crystal lattice node position of Ag2MoO4 crystal allows for overcoming the resistance of electron transition effectively. Meanwhile silver nano-particles on the surface of Ag@Ag2MoO4-AgBr composite could act as electron traps to intensify the photogeneration electron-hole separation and the subsequent transfer of the trapped electron to the adsorbed O2 as an electron acceptor. As an efficient visible light catalyst, the Ag@Ag2MoO4-AgBr composite exhibited superior photocatalytic activity for the degradation of various organic dyes. The experimental results demonstrated superior photocatalytic rate of Ag@Ag2MoO4-AgBr composite compared to pure AgBr and Ag2MoO4 crystals (37.6% and 348.4% enhancement respectively). The Ag@Ag2MoO4-AgBr composite cloud degraded Rhodamin B, bromophenol blue, and amino black 10b completed in 7min.
